Lynn, Rachel C.
Weber, Evan W.
Sotillo, Elena
Gennert, David
Xu, Peng
Good, Zinaida
Anbunathan, Hima
Lattin, John
Jones, Robert
Tieu, Victor
Nagaraja, Surya
Granja, Jeffrey
de Bourcy, Charles F. A.
Majzner, Robbie
Satpathy, Ansuman T.
Quake, Stephen R.
Monje, Michelle
Chang, Howard Y.
Mackall, Crystal L.
Article History
Received: 7 September 2018
Accepted: 17 October 2019
First Online: 4 December 2019
Competing interests
: C.L.M., R.C.L., E.W.W. and E.S. are inventors on a Stanford University Provisional patent pending on modulating AP-1 to enhance function of T cells; 62/599,299; C.L.M. is a founder of, holds equity in and receives consulting fees from Lyell Immunopharma, which has licensed the technology. R.C.L. is employed by and E.W.W. and E.S. are consultants for Lyell Immunopharma.